Decision Support in Illinois

VirtuSense is a healthcare technology company specializing in spatial artificial intelligence solutions for acute care environments. The company's flagship product, VSTOne®, is a single-source platform designed to bring hospital rooms into the future through autonomous patient monitoring and clinical decision support. VSTOne operates on a 99.99% accuracy rate and integrates with Epic MyChart to assist clinicians and patients. The platform addresses multiple clinical use cases within a single device, including autonomous fall prevention monitoring, pressure injury prevention, patient monitoring with hybrid human/AI capabilities, virtual nursing with ambient listening and automated clinical note capture, in-room patient AI assistance, violent patient alerting, and real-time location services (RTLS) with handwashing compliance tracking. The solution is designed to eliminate never events and simplify hospital workflows by enabling passive monitoring while clinicians focus on active care tasks. VirtuSense serves a diverse continuum of care including health systems, hospitals, primary care, skilled nursing facilities, assisted living, memory care, and therapy providers. The company reports significant clinical and operational impact, including fall prevention, reduction in false alarms, and measurable medical cost savings. VirtuSense serves major healthcare institutions including Cleveland Clinic, NYU Langone Health, UNC Health, and Mercy Health, among others.

ImPACT Applications, Inc. develops FDA-cleared medical devices for concussion assessment and management. The company's flagship product line—ImPACT, ImPACT Pediatric, and ImPACT Quick Test—comprises the longest-standing FDA-cleared computerized neurocognitive testing platforms designed to evaluate cognitive health, track post-concussion recovery, and support return-to-activity decisions. These assessments measure objective neurocognitive function (memory, processing speed, reaction time, and other cognitive domains) before and after injury, generating data-driven clinical insights. The company serves athletic programs (professional sports leagues, college athletics, youth sports), healthcare systems, urgent care facilities, emergency departments, and sports medicine practices. ImPACT's assessment tools are backed by the largest clinical research database in concussion management and have become the gold standard in neurocognitive baseline testing and post-concussion evaluation. Version 5 represents the latest release. The company offers customized training and virtual instruction for providers to ensure proper administration and interpretation. Primary markets include the United States across high school, college, and professional sports organizations, military and occupational health settings, and hospital-based concussion clinics.

Physician Software Systems develops a SaaS-based clinical decision support platform for precision dosing of medications with narrow therapeutic indices, with initial focus on erythropoietic stimulating agent (ESA) management for hemodialysis patients. The proprietary, Mayo Clinic-derived platform leverages patented algorithms and physiological modeling to deliver individualized dosing recommendations, reducing hemoglobin variability, minimizing drug costs, and improving patient outcomes. The system integrates seamlessly with existing electronic medical records (EMRs) to streamline clinician workflows, reduce manual calculation burden, and provide system-wide visibility across large patient populations. PhySoft's evidence-based approach is particularly valuable for tough-to-titrate drugs requiring frequent dose adjustments and complex clinical evaluation.

Higi is a consumer health engagement platform that operates a national network of FDA-cleared Smart Health Stations—self-screening kiosks deployed in supermarkets, pharmacies, and community locations. The platform enables individuals to measure, track, and manage their health data through an omnichannel approach combining physical kiosks, a mobile app, and digital tools. Smart Health Stations provide biometric screening including blood pressure, weight, and cardiovascular/diabetes risk assessments. Users create personal health accounts to monitor trends over time and access personalized health education. The company integrates with health systems, health plans, and retailers to support care coordination, health risk assessments, and navigation to community resources. As a Modivcare service, Higi reaches 34 million members and emphasizes HIPAA compliance and data security for health-related information.

Biocartis NV is a molecular diagnostics company specializing in fully automated, real-time PCR-based testing systems for personalized medicine. The company's flagship product, Idylla™, is a revolutionary automated molecular testing platform designed to deliver actionable biomarker results in approximately 3 hours. Idylla operates as a decentralized laboratory solution suitable for diverse healthcare settings, enabling pathologists and oncologists to obtain molecular diagnostic results rapidly for clinical decision-making. The system is particularly focused on oncology applications, where timely molecular biomarker analysis—including companion diagnostics—is critical for treatment selection and patient outcomes. Biocartis positions Idylla as addressing the challenge of making molecular testing easy, fast, and accessible to any laboratory, regardless of size or prior molecular expertise. The company supports oncology research into emerging biomarkers and maintains active partnership programs with pharmaceutical and in vitro diagnostics companies to expand the clinical utility of its platform. Biocartis' vision centers on enabling universal access to molecular testing globally, reducing barriers to personalized medicine adoption. The platform leverages automation and standardization to minimize hands-on time and technical variability, making molecular diagnostics suitable for point-of-care and decentralized laboratory environments.

Clinical Computer Systems, Inc. (CCSI) is a perinatal care technology company founded in 1996 and headquartered in Hoffman Estates, Illinois. The company develops and supports the OBIX Perinatal Data System—a cloud-enabled, integrated platform specializing in electronic fetal monitoring and labor & delivery workflow management. OBIX combines software-based decision support with wireless fetal monitoring hardware (OBIX BeCA Fetal Monitor) to enable real-time maternal and fetal vital signs monitoring at the bedside. The platform integrates with major EHR systems including MEDITECH and Veradigm, streamlining clinical documentation and data exchange. Key features include maternal alerts, decision support e-tools aligned with NICHD fetal heart rate standards, mobile charting and reporting, and wireless monitoring solutions. CCSI serves hospital enterprises across North America and internationally, supporting over 0+ facilities and monitoring thousands of deliveries annually. The company provides comprehensive implementation, technical support, online training, and extended support plans to optimize perinatal safety and clinical outcomes.

ASCEND Cardiovascular is a specialized cardiovascular IT solutions provider headquartered in Springfield, Illinois. Founded in 1995, the company develops enterprise-grade structured reporting and workflow software designed exclusively for cardiology departments and health systems. The ASCEND CV portfolio delivers multimodality structured reporting capabilities that integrate diagnostic, procedural, and reporting workflows into a unified cardiovascular ecosystem. Core offerings include ASCEND CV (multimodality reporting software), ASCEND InView (zero-footprint DICOM viewer), Gen3Echo (AI-driven echocardiography reporting), ASCEND Analytics (open-schema data warehouse), and Catalyst LIVE (telepresence collaboration platform). The company provides vendor-agnostic solutions with device interfaces, clinical decision support, and implementation services. ASCEND serves leading North American health systems and hospitals, with specialized solutions for pediatric cardiology, congenital heart disease, and non-invasive cardiac imaging. The platform integrates seamlessly with major EHR/HIS systems and medical device manufacturers including Epic, Cerner, GE Healthcare, Philips, and AGFA Healthcare.

Proteintech Group is a biotechnology company specializing in high-quality antibodies and protein research reagents for life sciences and pharmaceutical research. Founded in 2001 by scientists and headquartered in Rosemont, Illinois, the company manufactures a comprehensive catalog of antibodies, immunoassays, recombinant proteins, and nanobody-based reagents. Proteintech offers antibodies against 12,000+ human targets, 100+ sandwich ELISA kits, 4,000+ recombinant fusion proteins, and cGMP-grade cytokines and growth factors. Products include primary and secondary antibodies (monoclonal, polyclonal, and recombinant), conjugated antibodies for immunofluorescence and flow cytometry, immunohistochemistry kits, and magnetic cell separation kits. The company emphasizes in-house manufacturing, reproducibility, and a "scientists for scientists" approach, with products cited in over 20,000 peer-reviewed publications. Custom antibody services, polyclonal antibody production, and GMP-grade proteins support drug development and cell/gene therapy applications. Recently launched Able AI—a product recommendation tool—to accelerate scientific discovery.